Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind Trial
Journal of the National Comprehensive Cancer Network · 2025-01 · 23 (1)
DOI: 10.6004/jnccn.2024.7071 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2025-01. Verfasst von Sriram Yennurajalingam und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer, Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houst…. Hauptthemen laut MEDLINE: Fatigue, Dexamethasone, Neoplasms, Exercise. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: NINR NIH HHS.
Abstract (Originalsprache)
Background
Physical activity (PA) and dexamethasone (Dex) when used independently have modest benefits for cancer-related fatigue (CRF) in patients with advanced cancer. In this study we aimed to determine the feasibility (adherence, safety, and satisfaction) of combining PA with Dex versus PA with placebo (PBO) for CRF, and to explore the effects of PA+Dex and PA+PBO on CRF. Patients and Methods: In this phase II, randomized, double-blind controlled trial, eligible patients had advanced cancer and a CRF score of ≥4 on the Edmonton Symptom Assessment Scale (ESAS) for fatigue (0–10 scale). Patients were randomized to standardized PA for 4 weeks with either 4 mg of Dex (PA+Dex arm) or PBO (PA+PBO arm) twice daily for the first 7 days. Changes in Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT-F) scores from baseline to days 8 and 29 were assessed. Other outcomes included change in quality-of-life scores.
Results
A total of 64 (89%) patients were evaluable. Adherence rates for study medication, resistance exercise, and aerobic exercise were 91% and 92% ( P =.15), 83% and 70.6% ( P =.35), and 82.9% and 78.3% ( P =.73), respectively, in the PA+Dex and PA+PBO arms. The satisfaction rates for the PA+Dex and PA+PBO arms were 98% and 79%, respectively. Median (IQR) changes in FACIT-F scores at days 8 and 29 from baseline were 9 (2 to 16; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cancer, Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX.
Förderung
- NINR NIH HHS
Zitieren
APA
Yennurajalingam, S., Valero, V., Smalgo, B. G., Overman, M. J., Dasari, A., Wolff, R. A., Raghav, K. P. S., Barcenas, C. H., Busaidy, N. L., Fellman, B., Basen-Engquist, K., Hess, K. R., Tripathy, D., & Bruera, E. (2025). Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind Trial. Journal of the National Comprehensive Cancer Network, 23(1). https://doi.org/10.6004/jnccn.2024.7071
Vancouver
Yennurajalingam S, Valero V, Smalgo BG, Overman MJ, Dasari A, Wolff RA, et al. Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind Trial. Journal of the National Comprehensive Cancer Network. 2025;23(1). doi:10.6004/jnccn.2024.7071
BibTeX
@article{Yennurajalingam2025,
author = {Yennurajalingam, Sriram and Valero, Vicente and Smalgo, Brandon G and Overman, Michael J and Dasari, Aravind and Wolff, Robert A and Raghav, Kanwal Pratap Singh and Barcenas, Carlos H and Busaidy, Naifa L and Fellman, Bryan and Basen-Engquist, Karen and Hess, Kenneth R and Tripathy, Debasish and Bruera, Eduardo},
title = {Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind Trial},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2025},
volume = {23},
number = {1},
doi = {10.6004/jnccn.2024.7071}
}
EUVIMED